Snowball logo
logo
HRTX_logo

Heron Therapeutics, Inc

HRTX NASDAQ
$1.02-$0.11  (9.73%)

Frequently asked questions

What sector does Heron Therapeutics, Inc (HRTX) operate in?

Heron Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Heron Therapeutics, Inc (HRTX) current stock price?

As of the latest data, Heron Therapeutics, Inc stock price is $1.02, with a previous close of $1.13. Heron Therapeutics, Inc lost -$0.11 in the last trading session, representing a -9.73% loss.

What is Heron Therapeutics, Inc (HRTX) current market capitalization?

Heron Therapeutics, Inc market cap is approximately 187.03 million.

What is Heron Therapeutics, Inc (HRTX) Earnings Per Share (EPS)?

The trailing EPS is -$0.09, and the forward EPS is $0.51.

What is Heron Therapeutics, Inc (HRTX) EBITDA?

Heron Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -792.00 thousand.

Does Heron Therapeutics, Inc (HRTX) pay dividends?

No. Heron Therapeutics, Inc does not pay a dividend.

How did Heron Therapeutics, Inc (HRTX) perform in its most recent earnings report?

In the last report (December 31, 2025), Heron Therapeutics, Inc posted an EPS surprise of -33.33% and a revenue surprise of -73.62%.

What is Heron Therapeutics, Inc (HRTX) beta (volatility) score?

Heron Therapeutics, Inc has a beta of 1.299, suggesting it is more volatile than the market.